Sign in
Active, not recruitingNo phase

Perinatal Depression and Adverse Childhood Experiences: Prevention Trial

Key facts

Who runs it
Northwestern University
Where
Chicago, United StatesSee the site
Trial code
Status
Active, not recruiting
People taking part
76 people, planned
Started
20 Jul 2023
Ended
31 Oct 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Reach Out, Stand Strong, Essentials for New Mothers (ROSE) Program
Record updated
22 July 2026

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Age ≥ 18 years
  • At least one prenatal visit at Northwestern Medicine
  • Less than 24 weeks gestation
  • Non-anomalous pregnancy
  • English- or Spanish- speaking
  • ACE score ≥ 2
  • Singleton gestation

Who cannot take part

  • Active substance use disorder
  • Intent to delivery outside of Prentice Women's Hospital
  • Active major depressive episode
  • Participation in a study with a competing intervention or outcome

Where in United States

  • Northwestern MedicineChicago, United States

About the trial

What the trial wants to find out

The goal of this clinical trial is to evaluate the impact of ROSE in individuals with adverse childhood experiences. The main question it aims to answer is, compared to enhanced treatment as usual, does the delivery of ROSE within a collaborative care model improve depressive symptom trajectories and prevent the development of perinatal depression.

Read full original descriptionShow less

Participants will be randomized to either enhanced treatment as usual or the ROSE intervention, delivered by a care manager within a perinatal collaborative care program. They will complete self-reported surveys of their depression symptoms every 4 weeks to inform their symptom trajectories. They will also complete clinical interviews to establish any incident diagnoses of a major depressive episode.

The 2 groups in the trial

  • Enhanced treatment as usualNo study treatment, for comparison

    Those randomized to enhanced treatment as usual will receive brief psychoeducation about perinatal depression and the associations between ACEs and perinatal depression. Information about the collaborative care program will be provided. Individuals will be followed with monthly self-reported screens for depression, without any prevention programming for perinatal depression. Those identified to have incident depression symptoms will receive recommendations for treatment within the collaborative care model.

  • ROSE interventionTreatment being tested

    Those randomized to the intervention will be offered 4 prenatal sessions and one postpartum "booster" session guided by the Reach Out, Stand Strong, Essentials for New Mothers (ROSE) program embedded within the collaborative care model. Participants will be followed with monthly self-reported screens for depression, and those identified to have incident depression symptoms will receive treatment within the collaborative care model.

    Treatment: Reach Out, Stand Strong, Essentials for New Mothers (ROSE) Program

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Prevention of Perinatal Depression in Birthing People With a History of Adverse Childhood Experiences: A Type 2 Effectiveness Implementation Trial
Record updated
22 July 2026